In the fall of 2015, The Wall Street Journal ran an article on its front page which effectively set the biotechnology world and the insular Silicon Valley scene on fire. Theranos, a much hailed startup which was disrupting the world of healthcare and led by a visionary young woman, was a fraud, the story claimed.To most people, the article amounted to nothing short of blasphemy. To stain the reputation of Elizabeth Holmes and her company, valu...
CHF 24.50